New Program: Loss Quant + COVID-19

LESA has a new program coming up entitled, “Loss Quant + COVID-19: Identifying, Measuring, and Segregating COVID-19 Impact in Quantifying Losses“. Join us online to hear an updated view on how COVID-19 has impacted different industries, and by extension how loss quantification should be approached. If you practice in civil and/or commercial litigation or work with shareholder disputes, this webinar will be of particular interest to you. Scroll below for details and to meet our presenters.

Webinar Topics
  • COVID-19 timeline, including the changes in stock indices and the impact on industries
  • A review of loss quantification tools and how to adapt them for COVID-19
  • Impact on loss quantification methodology during COVID-19
Faculty

Richa Bhagrath, CBV, Deloitte 

Richa is a Director in Deloitte’s Valuation & Modelling practice focusing on business and intangible asset valuations, as well as damage quantification for litigation support purposes. Richa has completed valuations, for both public and private companies, to support mergers and acquisitions, including fairness opinions and formal valuations under MI 61-101, for regulatory purposes, and strategic planning. Read more…

 

Spencer Ord, MBA, CPA, CA, CBV, CFF, Deloitte 

Spencer has worked with government bodies, owner-managed businesses, and large multinational companies in a variety of industries. He is currently the Dispute Advisory Services leader for Edmonton at Deloitte and provides expert opinions for financial impact assessments in litigation and dispute matters, expropriations, damages quantification, and business valuations. He has been qualified as an expert witness by the Court of Queen’s Bench of Alberta. Read more…

Webinar Details

Date: February 3, 2022

Time:  12:00 PM – 1:30 PM

Price: $95 + GST

Register online here.

Shopping Cart
Scroll to Top

Connect

Customer Support

Community

EMAIL SIGN UP

Sign up to receive email notification of LESA programs and resources directly related to your practice.